Kunshan Guoke, a shareholder of Guangzhou Hexin Instrument (688622.SH), intends to reduce its holdings by no more than 1%.
*ST Hexin (688622.SH) announced that its shareholder holding more than 5%, Kunshan Guoke Venture Capital Co., Ltd. (referred to as "Kunshan Guoke"), intends to reduce its shareholding in the company through centralized bidding, with a total reduction not exceeding 704,700 shares, and the total reduction ratio not exceeding 1% of the company's total share capital. The reduction period will be within three months starting from 15 trading days after the announcement is disclosed.
Guangzhou Hexin Instrument (688622.SH) announced that its shareholder holding more than 5%, Kunshan Guoke Venture Capital Co., Ltd. (referred to as Kunshan Guoke), plans to reduce its holdings of the company's shares by no more than 704,700 shares through centralized bidding, with a total reduction not exceeding 1% of the company's total share capital. The reduction period will be within three months after the 15 trading days following the announcement date.
Related Articles
KUAISHOU-W (01024) spent HKD 14,991,800 to repurchase 442,000 shares on September 7.
HUNLICAR GROUP (03638): Zhang Lieyun resigns as executive director
Novo Nordisk A/S Sponsored ADR Class B (NVO.US) expands its weight loss drug to younger markets: The STEP Young trial shows that semaglutide significantly reduces obesity rates in children.
KUAISHOU-W (01024) spent HKD 14,991,800 to repurchase 442,000 shares on September 7.
HUNLICAR GROUP (03638): Zhang Lieyun resigns as executive director
Novo Nordisk A/S Sponsored ADR Class B (NVO.US) expands its weight loss drug to younger markets: The STEP Young trial shows that semaglutide significantly reduces obesity rates in children.
RECOMMEND
